16 results · 27ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ARGYLE NEO-SERT HYDROPHILIC POLYURETHANE UMBILICAL VESSEL CATHETER INSERTION TRAY

FDA 510(k)
FDA Class 2 ·General Hospital

Ophthalmic Forceps

FDA UDI
KATENA PRODUCTS, INC.·00841668106587·LESTER FIXATION FORCEPS 1X2 TEETH

7200 MICROPROCESSOR VENTILATOR SYSTEM RESPIRATORY

FDA 510(k)
FDA Class 2 ·Anesthesiology

eufy Wearable Breast Pump (T600P, T6000, T6001, T6002, T6003, T6004, T6005, T6006, T6007, T6008, T6009)

FDA 510(k)
FDA Class 2 ·Obstetrics/Gynecology

PREMICATH PICC

FDA Adverse Event
Malfunction ·VYGON GMBH·Product code LJS·May 20, 2015

PREMICATH PICC

FDA Adverse Event
Malfunction ·VYGON GMBH·Product code LJS·May 22, 2015

PREMICATH

FDA Adverse Event
Malfunction ·VYGON GMBH·Product code LJS·April 20, 2015

PREMICATH

FDA Adverse Event
VYGON GMBH·Product code LJS·April 20, 2015

PREMICATH PICC

FDA Adverse Event
Malfunction ·VYGON GMBH·Product code LJS·June 3, 2015

LIFEVEST WCD 4000 SYSTEM

FDA Adverse Event
Malfunction ·ZOLL LIFECOR CORPORATION·Product code MVK·January 9, 2013

OT VERIO IQ METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·July 24, 2014

ASR ACETABULAR CUPS 48

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL, LTD.·Product code KWA·January 5, 2011

ORTHOPEDIC SALVAGE SYSTEM MOD ARTHRO 0 DEG LCK COLLAR

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code HSB·June 12, 2024

23GA ILLUMINATED DIRECTIONAL LASER PROBE

FDA Adverse Event
Injury ·BAUSCH + LOMB·Product code HQB·March 19, 2020

25GA ILLUMINATED DIRECTIONAL LASER PROBE

FDA Adverse Event
Injury ·BAUSCH + LOMB·Product code HQB·March 19, 2020

Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017